+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Anticonvulsants"

Dravet Syndrome (DS) Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Dravet Syndrome (DS) Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Migraine Epidemiology Forecast 2026-2035 - Product Thumbnail Image

Migraine Epidemiology Forecast 2026-2035

  • Report
  • May 2026
  • 100 Pages
  • Global
From
Krabbe Disease Epidemiology Forecast 2025-2034 - Product Thumbnail Image

Krabbe Disease Epidemiology Forecast 2025-2034

  • Report
  • March 2026
  • 150 Pages
  • Global
From
Chronic Neuropathic Pain Pipeline Analysis Report 2025 - Product Thumbnail Image

Chronic Neuropathic Pain Pipeline Analysis Report 2025

  • Report
  • March 2026
  • 200 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
Diabetic Neuropathic Pain - Global Strategic Business Report - Product Thumbnail Image

Diabetic Neuropathic Pain - Global Strategic Business Report

  • Report
  • October 2026
  • 384 Pages
  • Global
From
From
Loading Indicator

Anticonvulsants are a class of drugs used to treat seizures and other neurological disorders. They work by reducing the abnormal electrical activity in the brain that causes seizures. Anticonvulsants are used to treat a variety of conditions, including epilepsy, bipolar disorder, and neuropathic pain. They are also used to prevent seizures in people with certain types of brain injuries. Anticonvulsants are part of the larger class of Central Nervous System (CNS) drugs, which also includes antidepressants, antipsychotics, and anxiolytics. The anticonvulsant market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include Pfizer, GlaxoSmithKline, Novartis, Sanofi, and Johnson & Johnson. Other companies include Mylan, Teva Pharmaceuticals, and Sun Pharmaceuticals. Show Less Read more